Chhabra, Avneesh
Deshmukh, Swati D.
Lutz, Amelie M.
Fritz, Jan
Sneag, Darryl B.
Mogharrabi, Bayan
Guirguis, Mina
Andreisek, Gustav
Xi, Yin
Ahlawat, Shivani
Article History
Received: 7 March 2022
Revised: 18 April 2022
Accepted: 19 April 2022
First Online: 27 April 2022
Declarations
:
: The authors declare that they have no conflict of interest
: <b>AC:</b> Consultant: ICON Medical and TREACE Medical Concepts Inc., Book Royalties: Jaypee, Wolters, Speaker: Siemens, Medical advisor and research grant: Image biopsy Inc.<b>JF:</b> Research support: Siemens AG, BTG international, Synthetic MR, Zimmer Biomed, Debuy Synthes and QED. Patents: JHU and Siemens AG. Advisory board: Image biopsy lab, Siemens AG, BTG international, QED, Synthetic MR, GE healthcare, Boston scientific and Mirata pharma.<b>AL:</b> Research support: GE healthcare and Bracco Diagnostics Inc. Patents: Stanford University.<b>SA:</b> Research support: Neurofibromatosis Therapeutic Acceleration Program, Department of Defense. Medical Advisor: Children’s Tumor Foundation, Gilbert Family FoundationDBS: Hospital for Special Surgery has an institutional research agreement with GE Healthcare and Siemens Healthineers.